Premium
SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB IN COMBINATION WITH TAZEMETOSTAT IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B STUDY
Author(s) -
Palomba M.L.,
Cartron G.,
Popplewell L.,
Ribrag V.,
Westin J.,
Chitra S.,
Huw L.,
Newberry K.,
Raval A.,
Xu J.,
Morschhauser F.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.203_2631
Subject(s) - medicine , tolerability , neutropenia , gastroenterology , refractory (planetary science) , diffuse large b cell lymphoma , oncology , surgery , adverse effect , lymphoma , toxicity , physics , astrobiology